Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities

Steroids

Volumn 72, Issue 5, 2007, Pages 406-414

  Krstić, Natalija M ^a   Bjelaković, Mira S ^a   Žižak, Željko ^b   Pavlović, Mirjana D ^c   Juranić, Zorica D ^b   Pavlović, Vladimir D ^a,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antiproliferative activity; Steroidal lactams; Steroidal oximes; Steroidal thiolactams

Indexed keywords

6 AZA 7 THIOXO B HOMOCHOLEST 4 ENE; 6 AZA B HOMOCHOLEST 4 EN 7 ONE; 6 THIOXO 7 AZA B HOMOCHOLEST 4 ENE; 7 AZA B HOMOCHOLEST 4 EN 6 ONE; ANTINEOPLASTIC AGENT; CHOLEST 4 EN 6 ON OXIME; LACTAM DERIVATIVE; OXIME DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; K562 CELLS; LACTAMS; LEUKOCYTES, MONONUCLEAR; OXIMES; STEROIDS; SULFHYDRYL COMPOUNDS;

EID: 34247205206     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.02.005     Document Type: Article

References (33)

1. Xie W., Peng H., Zalkow L.H., Li Y., Zhu C., Powis G., et al. 3β-Hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activity. Bioorg Med Chem 8 (2000) 699-706
2. Kasal A., Matyas L., and Budesinsky M. Neurosteroid analogues: synthesis of 6-aza-allopregnanolone. Tetrahedron 61 (2005) 2269-2278
3. Metcalf B.W., Levy M.A., and Holt D.A. Inhibitors of 5α-reductase in beningn prostatic hyperplasia, male pattern baldness and acne. Trends Pharm Sci 10 (1989) 491-593
4. Liang T., Rasmusson G.H., and Brooks J.R. 12. Androgens: pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5-alpha-reductase inhibitors. J Steroid Biochem 19 (1983) 385-390
5. Rasmusson G.H., Reynolds G.F., Steinberg N.G., Walton E., Pate G.F., Liang T., et al. Azasteroids: structure-activity relationships for inhibition of 5α-reductase and androgen receptor binding. J Med Chem 29 (1986) 2298-2315
6. Di Salle E., Guidici D., Briatico G., Ornati G., and Panzeri A. Hormonal effects of turosteride, a 5α-reductase inhibitor, in the rat. J Steroid Biochem Mol Biol 46 (1993) 549-555
7. Guarna A., Belle C., Machetti F., Occhiato E.G., and Payne A.H. 19-Nor-10-azasteroids: a novel class of inhibitors for human steroid 5α-reductase 1 and 2. J Med Chem 40 (1997) 1112-1129
8. Guarna A., Occhiato E.G., and Machetti F. 19-Nor-10-azasteroids, a new class of steroid 5α-reductase inhibitors. 2.1 X-ray structure. molecular modeling. Conformational analysis of 19-Nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids. J Med Chem 40 (1997) 3466-3477
9. Jindal D.P., Chattopadhaya R., Guler S., and Gupta R. Synthesis and antineoplastic activity of 2-alkylaminoethyl derivatives of various steroidal oximes. Eur J Med Chem 38 (2003) 1025-1034
10. Formestane R.C. Antineoplastic, Aromatase Inhibitor: Drugs of the Future. Prous Science (1993) p. 599
11. Holland H.L., Kumaresan S., Tan L., and Njar V.C.O. Synthesis of 6-hydroximino-3-oxo steroids, a new class of aromatase inhibitor. J Chem Soc Perkin Trans 1 13 (1992) 585-587
12. Catsoulacos P., Politis D., and Wampler G.L. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid. Cancer Chemother Pharmacol 10 (1983) 129-132
13. Trafalis D.T.P., Sambani C., Kapsimali V., Economidou J., Politis G., and Catsoulacos P. Effects of homo-aza-steroids on acute non-lymphocytic leukemia cell proliferation in vitro. Br J Hematol 91 (1995) 907-914
14. Trafalis D.T.P., Tsavdaridis D., Camoutsis C., Karayiani V., Chrysogelou E., Dalezis P., et al. Precilinical studies on NSC290205 aza-steroid alkylator in combination with adriamycin against lymphoid leukemia. Br J Hematol 128 (2004) 343-350
15. Shuster A.M., Gololobov G.V., Kvashuk O.A., Bogomolova A.E., Smirnov I.V., and Gabibov A.G. DNA hydrolyzing autoantibodies. Science 256 (1992) 665-667
16. Kozyr A.V., Sashchenko L.P., Kolesnikow A.V., Zelenova N.A., Khaidukov S.V., Ignatova A.N., et al. Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett 80 1 (2002) 41-47
17. Nevinsky G.A., Breusov A.A., Baranovskii A.G., Prints A.V., Kanyshkova T.G., Galyita A.V., et al. Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med Sci Monit 7 (2001) 201-211
18. Dubrovskaya V.V., Andryushkova A.S., Kuznetsova I.A., Toporkova L.B., Buneva V.N., Orlovskaya I.A., et al. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice. Biochemistry (Mosc) 68 (2003) 1081-1088
19. Krstić N.M., Bjelaković M.S., Dabović M.M., Lorenc L.j.B., and Pavlović V.D. Photochemical and Beckmann rearrangement of (Z)-cholest-4-en-6-one oxime. J Serb Chem Soc 69 (2004) 413-420
20. Pavlović V.D., Dabović M.M., Martinović S., Lorenc L.j.B., and Kalvoda J. Synthesis of 5-azaandrostane-3β,17β-diol protected at the 17β-hydroxyl group. J Serb Chem Soc 69 (2004) 861-869
21. Clothier R.H. The FRAME cytotoxicity test. Meth Mol Biol 43 (1995) 109-118
22. Martin S.J., Lennon S.V., Bonham A.M., and Cotter T.G. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145 (1990) 1859-1867
23. Suginome H., Ohshima K., Ohue Y., Ohki T., and Senboku H. Photoinduced molecular transformations. Part 149. Stereospecific photoadditions and photorearrangements of the oximes of some steroidal α,β-unsaturated cyclic ketones and their deutero derivatives. J Chem Soc Perkin Trans 1 (1994) 3239-3250
24. Grisenti P., Magni A., and Ferraboschi P. A practical routh for the synthesis of 17 substituted steroidal 3-thioxamides. Steroids 62 (1997) 504-506
25. Zhang Y., Wu L., Tashiro S., Onodera S., and Ikejima T. Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis. Acta Pharmacol Sin 25 (2004) 83-89
26. Darzynkiewicz Z., Xuan H., and Masaki O. Detection of DNA strand breaks by flow and laser scanning cytometry in studies of apoptosis and cell proliferation (DNA replication). Meth Mol Biol 314 (2006) 81-93
27. Kim B.E., Roh S.R., Kim J.W., Jeong S.W., and Kim I.K. Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. Exp Mol Med 34 (2003) 290-300
28. Koichi M., Koji Y., Yoichi T., Kozo N., Yusuke N., and Hirofumi. p53AIP1 Regulates the mitochondrial apoptotic pathway. Cancer Res 62 (2002) 2883-2889
29. Choi J.Y.K., Kim T.K., Kim C.J., Lee J.S., Joo S.H.S., Foster D.N., et al. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Exp Mol Med 38 (2006) 11-17
30. Yang S.H., Chien C.M., Lu M.C., Lu Y.J., Wu Z.Z., and Lin S.R. Cardiotoxin III induces apoptosis in K562 cells through a mitochondrial-mediated pathway. Clin Exp Pharmacol Physiol 32 (2005) 515-520
31. Wang H.Y., Cai B., Cui C.B., Zhang D.Y., and Yang B.F. Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway. Yao Xue Xue Bao 40 (2005) 27-31
32. Jacquel A., Herrant M., Legros L., Belhacene N., Luciano F., Pages G., et al. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl positive K562 cell line and its differentiation towards the erythroid lineage. FASEB J 17 (2003) 2160-2162
33. Yang L., Cao Z., Yan H., and Wood W.C. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 63 (2003) 6815-6824